PSA Test Might Overdiagnose Prostate Cancers in Black Men
FRIDAY, March 1, 2024 (HealthDay News) — A new British study suggests that the prostate-specific antigen (PSA) test, long used to spot prostate cancers, might lead to overdiagnosis in Black men. Researchers now theorize that Black men may have naturally higher levels of the antigen in their blood than whiteContinue Reading